TETRAHYDROQUINOLINE ANALOGUES AS MUSCARINIC AGONISTS
First Claim
Patent Images
1. A compound of formula (I), and salts and isomers thereof wherein:
- m is 0, 1 or 2;
C3-C4 is CH2—
CR1R9 or CH═
CR1 or C4 is CR1R9 and C3 is absent;
each R1 and each R9 is separately selected from the group consisting of hydrogen, halogen, hydroxy, straight- or branched-chain optionally substituted C1-6 alkyl, straight- or branched-chain optionally substituted C2-6 alkenyl, straight- or branched-chain optionally substituted C2-6 alkynyl, straight- or branched-chain optionally substituted C1-6 alkylidene, straight- or branched-chain optionally substituted C1-6 alkoxy, straight- or branched-chain optionally substituted C1-6 heteroalkyl, straight- or branched-chain optionally substituted C1-6 aminoalkyl, straight- or branched-chain optionally substituted C1-6 haloalkyl, straight- or branched-chain optionally substituted C1-6 alkoxycarbonyl, straight- or branched-chain optionally substituted C1-6 hydroxyalkoxy, straight- or branched-chain optionally substituted C1-6 hydroxyalkyl, straight- or branched-chain optionally substituted C1-6 alkylthio, straight- or branched-chain optionally substituted —
O—
C2-6 alkenyl, straight- or branched-chain optionally substituted —
O—
C2-6 alkynyl, straight- or branched-chain optionally substituted C3-6 alkenylalkoxy, straight- or branched-chain optionally substituted C1-6 alkyloxyimino, straight- or branched-chain optionally substituted C1-6 alkyloxyamino, optionally substituted —
O—
CH2—
C5-6 aryl, —
C(O)NR10R11, —
CR10R11R12, —
OC(O)R10, straight- or branched-chain optionally substituted —
(O)(CH2)sNR11R12, straight- or branched-chain optionally substituted —
(CH2)sNR11R12, straight- or branched-chain optionally substituted OC(O)O(CH2)sCH3, straight- or branched-chain optionally substituted —
S—
C1-6-alkyl, straight- or branched-chain optionally substituted —
S—
C2-6-alkenyl, and straight- or branched-chain optionally substituted —
S—
C2-6-alkynyl, each of which may be optionally substituted with one or more substituents Rx;
each R10 is separately selected from the group consisting of hydrogen, straight- or branched-chain C1-6 alkyl, straight- or branched-chain C2-6 alkenyl, straight- or branched-chain C2-6 alkynyl, straight- or branched-chain C2-6 heteroalkyl, straight- or branched-chain C2-6 aminoalkyl, straight- or branched-chain C2-6 haloalkyl, straight- or branched-chain C1-6 alkoxycarbonyl, straight- or branched-chain C2-6 hydroxyalkyl, C3-8 cycloalkyl, —
C(O)—
C5-6 aryl substituted with C1-3 alkyl or halo, C5-6 aryl, C5-6 heteroaryl, C5-6 cycloalkyl, C5-6 heterocycloalkyl, —
C(O)NR11R12, —
CR11R12R13, and straight- or branched-chain —
(CH2)sNR11R12;
each s is separately selected to be an integer from 1 to 8;
each R11 and each R12 is separately selected from the group consisting of hydrogen, straight- or branched-chain C1-6 alkyl, C3-6 cycloalkyl, and C5-6 heteroaryl, or each R11 and R12 together form a C3-8 cycloalkyl or C3-8 heterocycloalkyl;
R13 is selected from the group consisting of hydrogen, halogen, straight- or branched-chain C1-6 alkyl, formyl, and C3-6 cycloalkyl;
each Rx is separately selected from the group consisting of hydrogen, halogen, hydroxy, straight- or branched-chain optionally substituted C1-6 alkyl, straight- or branched-chain optionally substituted C1-6 alkoxy, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 heterocyclyl, and straight- or branched-chain optionally substituted C1-6 alkylidene;
R2 and R3 are separately selected from the group consisting of hydrogen, optionally substituted C1-6 alkyl, optionally substituted O—
C1-6 alkyl, halogen, hydroxy or selected such that R2 and R3 are covalently linked together to form a ring system;
each R4 and each R5 are separately selected from the group consisting of hydrogen, halogen, hydroxy, optionally substituted C1-6-alkyl, optionally substituted O—
C1-6alkyl, optionally substituted aryl-C1-6alkyl, and optionally substituted arylheteroalkyl;
L1 and L2 are separately biradicals having the formula —
C(R6)═
C(R7)—
;
Y is selected from the group consisting of O, S, and H2; and
X is a biradical selected from the group consisting of —
C(R6)(R7)—
C(R6)(R7)— and
—
C(R6)═
C(R7)—
,wherein R6 and R7 are separately selected from the group consisting of hydrogen, halogen, hydroxy, nitro, cyano, NRNRN, N(RN)—
C(O)N(RN), optionally substituted C1-6-alkyl, C2-6-alkenyl, C2-6-alkynyl, optionally substituted O—
C1-6-alkyl, optionally substituted O-aryl, optionally substituted O—
C2-6-alkenyl, optionally substituted O—
C2-6-alkynyl,wherein RN is selected from the group consisting of hydrogen, and optionally substituted C1-6-alkyl.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to tetrahydroquinoline compounds as muscarinic receptor agonists; compositions comprising the same; methods of inhibiting an activity of a muscarinic receptor with said compounds; methods of treating a disease condition associated with a muscarinic receptor using said compounds; and methods for identifying a subject suitable for treatment using said compounds.
18 Citations
24 Claims
-
1. A compound of formula (I), and salts and isomers thereof
wherein: -
m is 0, 1 or 2; C3-C4 is CH2—
CR1R9 or CH═
CR1 or C4 is CR1R9 and C3 is absent;each R1 and each R9 is separately selected from the group consisting of hydrogen, halogen, hydroxy, straight- or branched-chain optionally substituted C1-6 alkyl, straight- or branched-chain optionally substituted C2-6 alkenyl, straight- or branched-chain optionally substituted C2-6 alkynyl, straight- or branched-chain optionally substituted C1-6 alkylidene, straight- or branched-chain optionally substituted C1-6 alkoxy, straight- or branched-chain optionally substituted C1-6 heteroalkyl, straight- or branched-chain optionally substituted C1-6 aminoalkyl, straight- or branched-chain optionally substituted C1-6 haloalkyl, straight- or branched-chain optionally substituted C1-6 alkoxycarbonyl, straight- or branched-chain optionally substituted C1-6 hydroxyalkoxy, straight- or branched-chain optionally substituted C1-6 hydroxyalkyl, straight- or branched-chain optionally substituted C1-6 alkylthio, straight- or branched-chain optionally substituted —
O—
C2-6 alkenyl, straight- or branched-chain optionally substituted —
O—
C2-6 alkynyl, straight- or branched-chain optionally substituted C3-6 alkenylalkoxy, straight- or branched-chain optionally substituted C1-6 alkyloxyimino, straight- or branched-chain optionally substituted C1-6 alkyloxyamino, optionally substituted —
O—
CH2—
C5-6 aryl, —
C(O)NR10R11, —
CR10R11R12, —
OC(O)R10, straight- or branched-chain optionally substituted —
(O)(CH2)sNR11R12, straight- or branched-chain optionally substituted —
(CH2)sNR11R12, straight- or branched-chain optionally substituted OC(O)O(CH2)sCH3, straight- or branched-chain optionally substituted —
S—
C1-6-alkyl, straight- or branched-chain optionally substituted —
S—
C2-6-alkenyl, and straight- or branched-chain optionally substituted —
S—
C2-6-alkynyl, each of which may be optionally substituted with one or more substituents Rx;each R10 is separately selected from the group consisting of hydrogen, straight- or branched-chain C1-6 alkyl, straight- or branched-chain C2-6 alkenyl, straight- or branched-chain C2-6 alkynyl, straight- or branched-chain C2-6 heteroalkyl, straight- or branched-chain C2-6 aminoalkyl, straight- or branched-chain C2-6 haloalkyl, straight- or branched-chain C1-6 alkoxycarbonyl, straight- or branched-chain C2-6 hydroxyalkyl, C3-8 cycloalkyl, —
C(O)—
C5-6 aryl substituted with C1-3 alkyl or halo, C5-6 aryl, C5-6 heteroaryl, C5-6 cycloalkyl, C5-6 heterocycloalkyl, —
C(O)NR11R12, —
CR11R12R13, and straight- or branched-chain —
(CH2)sNR11R12;each s is separately selected to be an integer from 1 to 8; each R11 and each R12 is separately selected from the group consisting of hydrogen, straight- or branched-chain C1-6 alkyl, C3-6 cycloalkyl, and C5-6 heteroaryl, or each R11 and R12 together form a C3-8 cycloalkyl or C3-8 heterocycloalkyl; R13 is selected from the group consisting of hydrogen, halogen, straight- or branched-chain C1-6 alkyl, formyl, and C3-6 cycloalkyl; each Rx is separately selected from the group consisting of hydrogen, halogen, hydroxy, straight- or branched-chain optionally substituted C1-6 alkyl, straight- or branched-chain optionally substituted C1-6 alkoxy, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 heterocyclyl, and straight- or branched-chain optionally substituted C1-6 alkylidene; R2 and R3 are separately selected from the group consisting of hydrogen, optionally substituted C1-6 alkyl, optionally substituted O—
C1-6 alkyl, halogen, hydroxy or selected such that R2 and R3 are covalently linked together to form a ring system;each R4 and each R5 are separately selected from the group consisting of hydrogen, halogen, hydroxy, optionally substituted C1-6-alkyl, optionally substituted O—
C1-6alkyl, optionally substituted aryl-C1-6alkyl, and optionally substituted arylheteroalkyl;L1 and L2 are separately biradicals having the formula —
C(R6)═
C(R7)—
;Y is selected from the group consisting of O, S, and H2; and X is a biradical selected from the group consisting of —
C(R6)(R7)—
C(R6)(R7)— and
—
C(R6)═
C(R7)—
,wherein R6 and R7 are separately selected from the group consisting of hydrogen, halogen, hydroxy, nitro, cyano, NRNRN, N(RN)—
C(O)N(RN), optionally substituted C1-6-alkyl, C2-6-alkenyl, C2-6-alkynyl, optionally substituted O—
C1-6-alkyl, optionally substituted O-aryl, optionally substituted O—
C2-6-alkenyl, optionally substituted O—
C2-6-alkynyl,wherein RN is selected from the group consisting of hydrogen, and optionally substituted C1-6-alkyl. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)
-
Specification